https://h.suprapedia.de/w/index.php?action=history&feed=atom&title=Clin_Appl_Thromb_Hemost
Clin Appl Thromb Hemost - Versionsgeschichte
2026-08-23T16:11:46Z
Versionsgeschichte dieser Seite in PlusPedia
MediaWiki 1.43.3
https://h.suprapedia.de/w/index.php?title=Clin_Appl_Thromb_Hemost&diff=227007&oldid=prev
AngelSlayerzuZK am 29. August 2011 um 19:23 Uhr
2011-08-29T19:23:12Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="de">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 29. August 2011, 19:23 Uhr</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l4">Zeile 4:</td>
<td colspan="2" class="diff-lineno">Zeile 4:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | [http://<del style="font-weight: bold; text-decoration: none;">cat.sagepub</del>.com/<del style="font-weight: bold; text-decoration: none;">content/by/year'''ARTIKEL </del>SUCHEN''']</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | [http://<ins style="font-weight: bold; text-decoration: none;">pillsm</ins>.com/<ins style="font-weight: bold; text-decoration: none;">?a=7539 </ins>SUCHEN''']</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr>
</table>
AngelSlayerzuZK
https://h.suprapedia.de/w/index.php?title=Clin_Appl_Thromb_Hemost&diff=223897&oldid=prev
Ariane: Änderungen von Puwok2008JBonx (Diskussion) rückgängig gemacht und letzte Version von Mutter Erde wiederhergestellt
2011-08-11T05:00:54Z
<p>Änderungen von <a href="/wiki/Spezial:Beitr%C3%A4ge/Puwok2008JBonx" title="Spezial:Beiträge/Puwok2008JBonx">Puwok2008JBonx</a> (<a href="/w/index.php?title=Benutzer_Diskussion:Puwok2008JBonx&action=edit&redlink=1" class="new" title="Benutzer Diskussion:Puwok2008JBonx (Seite nicht vorhanden)">Diskussion</a>) rückgängig gemacht und letzte Version von <a href="/wiki/Benutzer:Mutter_Erde" title="Benutzer:Mutter Erde">Mutter Erde</a> wiederhergestellt</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="de">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 11. August 2011, 05:00 Uhr</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l4">Zeile 4:</td>
<td colspan="2" class="diff-lineno">Zeile 4:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | [http://<del style="font-weight: bold; text-decoration: none;">pillsm</del>.com/<del style="font-weight: bold; text-decoration: none;">?a=7539 </del>SUCHEN''']</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | [http://<ins style="font-weight: bold; text-decoration: none;">cat.sagepub</ins>.com/<ins style="font-weight: bold; text-decoration: none;">content/by/year'''ARTIKEL </ins>SUCHEN''']</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr>
</table>
Ariane
https://h.suprapedia.de/w/index.php?title=Clin_Appl_Thromb_Hemost&diff=223894&oldid=prev
Puwok2008JBonx am 11. August 2011 um 04:57 Uhr
2011-08-11T04:57:13Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="de">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 11. August 2011, 04:57 Uhr</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l4">Zeile 4:</td>
<td colspan="2" class="diff-lineno">Zeile 4:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | [http://<del style="font-weight: bold; text-decoration: none;">cat.sagepub</del>.com/<del style="font-weight: bold; text-decoration: none;">content/by/year'''ARTIKEL </del>SUCHEN''']</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | [http://<ins style="font-weight: bold; text-decoration: none;">pillsm</ins>.com/<ins style="font-weight: bold; text-decoration: none;">?a=7539 </ins>SUCHEN''']</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr>
</table>
Puwok2008JBonx
https://h.suprapedia.de/w/index.php?title=Clin_Appl_Thromb_Hemost&diff=222706&oldid=prev
Mutter Erde: Änderungen von MishelUaOD (Diskussion) rückgängig gemacht und letzte Version von Ossip Groth wiederhergestellt
2011-08-04T10:22:14Z
<p>Änderungen von <a href="/wiki/Spezial:Beitr%C3%A4ge/MishelUaOD" title="Spezial:Beiträge/MishelUaOD">MishelUaOD</a> (<a href="/w/index.php?title=Benutzer_Diskussion:MishelUaOD&action=edit&redlink=1" class="new" title="Benutzer Diskussion:MishelUaOD (Seite nicht vorhanden)">Diskussion</a>) rückgängig gemacht und letzte Version von <a href="/wiki/Benutzer:Ossip_Groth" title="Benutzer:Ossip Groth">Ossip Groth</a> wiederhergestellt</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="de">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 4. August 2011, 10:22 Uhr</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l4">Zeile 4:</td>
<td colspan="2" class="diff-lineno">Zeile 4:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | [http://<del style="font-weight: bold; text-decoration: none;">pillsm</del>.com/<del style="font-weight: bold; text-decoration: none;">?a=7539 </del>SUCHEN''']</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | [http://<ins style="font-weight: bold; text-decoration: none;">cat.sagepub</ins>.com/<ins style="font-weight: bold; text-decoration: none;">content/by/year'''ARTIKEL </ins>SUCHEN''']</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr>
</table>
Mutter Erde
https://h.suprapedia.de/w/index.php?title=Clin_Appl_Thromb_Hemost&diff=222705&oldid=prev
MishelUaOD am 4. August 2011 um 10:16 Uhr
2011-08-04T10:16:18Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="de">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 4. August 2011, 10:16 Uhr</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l4">Zeile 4:</td>
<td colspan="2" class="diff-lineno">Zeile 4:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | [http://<del style="font-weight: bold; text-decoration: none;">cat.sagepub</del>.com/<del style="font-weight: bold; text-decoration: none;">content/by/year'''ARTIKEL </del>SUCHEN''']</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | [http://<ins style="font-weight: bold; text-decoration: none;">pillsm</ins>.com/<ins style="font-weight: bold; text-decoration: none;">?a=7539 </ins>SUCHEN''']</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr>
</table>
MishelUaOD
https://h.suprapedia.de/w/index.php?title=Clin_Appl_Thromb_Hemost&diff=110350&oldid=prev
Ossip Groth: Die Seite wurde neu angelegt: „<ref name="PMID20460338">Nontraditional risk factors in carotid artery disease. Clin Appl Thromb Hemost 16(5):554-8 (2010) PMID 20460338 </ref><ref name="PMID1922…“
2010-10-05T19:02:58Z
<p>Die Seite wurde neu angelegt: „<ref name="PMID20460338">Nontraditional risk factors in carotid artery disease. Clin Appl Thromb Hemost 16(5):554-8 (2010) PMID 20460338 </ref><ref name="PMID1922…“</p>
<p><b>Neue Seite</b></p><div><ref name="PMID20460338">Nontraditional risk factors in carotid artery disease. Clin Appl Thromb Hemost 16(5):554-8 (2010) PMID 20460338 </ref><ref name="PMID19221100">Laboratory evaluation of antiphospholipid antibodies in patients with venous thromboembolism. Clin Appl Thromb Hemost 16(3):318-25 (2010) PMID 19221100 </ref><ref name="PMID19028773">Lessons from ximelagatran: issues for future studies evaluating new oral direct thrombin inhibitors for venous thromboembolism prophylaxis in orthopedic surgery. Clin Appl Thromb Hemost 15(3):316-26 (2009) PMID 19028773 </ref><ref name="PMID18930954">Glanzmann's thrombasthenia: an overview. Clin Appl Thromb Hemost 15(2):152-65 (2009) PMID 18930954 </ref><ref name="PMID18160570">Coagulation activation by lipopolysaccharides. Clin Appl Thromb Hemost 15(2):209-19 (2009) PMID 18160570 </ref><ref name="PMID18160562">Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series. Clin Appl Thromb Hemost 15(2):225-32 (2009) PMID 18160562 </ref><ref name="PMID18160571">Management of uremic patients with heparin-induced thrombocytopenia requiring hemodialysis. Clin Appl Thromb Hemost 14(4):459-64 (2008) PMID 18160571 </ref><ref name="PMID17895512">Serologic results in &gt;1000 patients with suspected heparin-induced thrombocytopenia. Clin Appl Thromb Hemost 14(4):410-4 (2008) PMID 17895512 </ref><ref name="PMID18160568">Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis. Clin Appl Thromb Hemost 14(3):360-4 (2008) PMID 18160568 </ref><ref name="PMID18182681">Rectus sheath hematoma due to inappropriate warfarin usage. Clin Appl Thromb Hemost 14(1):116-7 (2008) PMID 18182681 </ref><ref name="PMID17456628">Heparin-induced thrombocytopenia in a uremic patient requiring hemodialysis: an alternative treatment and reexposure to heparin. Clin Appl Thromb Hemost 13(2):182-7 (2007) PMID 17456628 </ref><ref name="PMID16959679">Thromboembolism in cancer patients: pathogenesis and treatment. Clin Appl Thromb Hemost 12(3):254-66 (2006) PMID 16959679 </ref><ref name="PMID16708123">Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study. Clin Appl Thromb Hemost 12(2):205-12 (2006) PMID 16708123 </ref><ref name="PMID16444443">Warfarin-induced skin necrosis: a case report. Clin Appl Thromb Hemost 12(1):101-4 (2006) PMID 16444443 </ref><ref name="PMID16444439">Extreme thrombocytosis: what are the etiologies? Clin Appl Thromb Hemost 12(1):85-7 (2006) PMID 16444439 </ref><ref name="PMID16444436">Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activity. Clin Appl Thromb Hemost 12(1):61-7 (2006) PMID 16444436 </ref><ref name="PMID16444433">Antiphospholipid-mediated thrombosis: interplay between anticardiolipin antibodies and vascular cells. Clin Appl Thromb Hemost 12(1):41-5 (2006) PMID 16444433 </ref><ref name="PMID16015414">Prevention of edema in long flights with Pycnogenol. Clin Appl Thromb Hemost 11(3):289-94 (2005) PMID 16015414 </ref><ref name="PMID12516686">Tissue factor and thrombomodulin in hemodialysis patients: associations with endothelial injury, liver disease, and erythropoietin therapy. Clin Appl Thromb Hemost 8(4):359-67 (2002) PMID 12516686 </ref><ref name="PMID12516680">Thrombolytic therapy. Clin Appl Thromb Hemost 8(4):291-314 (2002) PMID 12516680 </ref><ref name="PMID12361207">Association of platelet-derived microparticles with C-C chemokines on vascular complication in patients with acute myocardial infarction. Clin Appl Thromb Hemost 8(3):279-86 (2002) PMID 12361207 </ref><ref name="PMID12361205">Plasma levels of heparin cofactor II (HCII) and thrombin-HCII complex in patients with disseminated intravascular coagulation. Clin Appl Thromb Hemost 8(3):265-71 (2002) PMID 12361205 </ref><ref name="PMID12361202">Effect of hemodialysis on plasma levels of vascular endothelial markers. Clin Appl Thromb Hemost 8(3):245-50 (2002) PMID 12361202 </ref><ref name="PMID12361196">Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions. Clin Appl Thromb Hemost 8(3):193-212 (2002) PMID 12361196 </ref><ref name="PMID11441978">Vascular thrombohemorrhagic disorders: hereditary and acquired. Clin Appl Thromb Hemost 7(3):178-94 (2001) PMID 11441978 </ref><ref name="PMID20724304">Failure to lyse venous thrombi because of elevated plasminogen activator Inhibitor 1 (PAI-1) and 4G polymorphism of its promotor genome (The PAI-1/4G Syndrome). Clin Appl Thromb Hemost 16(5):574-8 (2010) PMID 20724304 </ref><ref name="PMID20699255">State-of-the-art review: Hemostats, sealants, and adhesives II: Update as well as how and when to use the components of the surgical toolbox. Clin Appl Thromb Hemost 16(5):497-514 (2010) PMID 20699255 </ref><ref name="PMID19833624">Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper. Clin Appl Thromb Hemost 16(4):446-53 (2010) PMID 19833624 </ref><ref name="PMID19833621">Low dose of argatroban saline flushes anticoagulation in hemodialysis patients with high risk of bleeding. Clin Appl Thromb Hemost 16(4):440-5 (2010) PMID 19833621 </ref><ref name="PMID19752039">Lipoprotein (a) levels in childhood arterial ischemic stroke. Clin Appl Thromb Hemost 16(2):214-7 (2010) PMID 19752039 </ref><ref name="PMID19117965">Effect of sulodexide on plasma transforming growth factor-beta1 in healthy volunteers. Clin Appl Thromb Hemost 16(1):60-5 (2010) PMID 19117965 </ref><ref name="PMID19605376">Effect of recombinant activated factor VII in critical bleeding: clinical experience of a single center. Clin Appl Thromb Hemost 15(6):628-35 (2009) PMID 19605376 </ref><ref name="PMID18818230">Acute massive pulmonary embolism with hemodynamic compromise treated successfully with thrombolytic therapy. Clin Appl Thromb Hemost 15(6):708-10 (2009) PMID 18818230 </ref><ref name="PMID19088098">Use of aspirin versus clopidogrel plus aspirin after coronary artery bypass graft surgery. Clin Appl Thromb Hemost 15(5):540-4 (2009) PMID 19088098 </ref><ref name="PMID18160609">Pleiotropic effects of heparin and heparinoids in peritoneal dialysis. Clin Appl Thromb Hemost 15(1):92-7 (2009) PMID 18160609 </ref><ref name="PMID18160611">Further insight into the heparin-releasable and glycosylphosphatidylinositol-lipid--anchored forms of tissue factor pathway inhibitor. Clin Appl Thromb Hemost 14(3):267-78 (2008) PMID 18160611 </ref><ref name="PMID18160589">Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions. Clin Appl Thromb Hemost 14(3):286-94 (2008) PMID 18160589 </ref><ref name="PMID18160608">Heparin-induced thrombocytopenia complicating hemodialysis. Clin Appl Thromb Hemost 14(1):105-7 (2008) PMID 18160608 </ref><ref name="PMID18160593">Homocysteine activates platelets in vitro. Clin Appl Thromb Hemost 14(1):8-18 (2008) PMID 18160593 </ref><ref name="PMID17636188">Singlet oxygen potentiates thrombolysis. Clin Appl Thromb Hemost 13(3):259-78 (2007) PMID 17636188 </ref><ref name="PMID17636185">Evaluation of off-label recombinant activated factor VII for multiple indications in children. Clin Appl Thromb Hemost 13(3):233-40 (2007) PMID 17636185 </ref><ref name="PMID17000885">Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease. Clin Appl Thromb Hemost 12(4):397-420 (2006) PMID 17000885 </ref><ref name="PMID16959685">Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenol. Clin Appl Thromb Hemost 12(3):318-23 (2006) PMID 16959685 </ref><ref name="PMID16708117">The role of adiponectin in atherosclerosis and thrombosis. Clin Appl Thromb Hemost 12(2):163-8 (2006) PMID 16708117 </ref><ref name="PMID16708116">Thrombin generation by exposure of blood to endotoxin: a simple model to study disseminated intravascular coagulation. Clin Appl Thromb Hemost 12(2):137-61 (2006) PMID 16708116 </ref><ref name="PMID16708115">Hereditary and acquired thrombophilic disorders. Clin Appl Thromb Hemost 12(2):125-35 (2006) PMID 16708115 </ref><ref name="PMID16244777">Effects of high-dose methylprednisolone therapy on coagulation factors in patients with acute immune thrombocytopenic purpura. Clin Appl Thromb Hemost 11(4):489-92 (2005) PMID 16244777 </ref><ref name="PMID16244775">Clinico-hematologic profile of factor XIII-deficient patients. Clin Appl Thromb Hemost 11(4):475-80 (2005) PMID 16244775 </ref><ref name="PMID16244771">Plasma levels of thrombin-activatable fibrinolysis inhibitor in primary and secondary thrombocytosis. Clin Appl Thromb Hemost 11(4):449-54 (2005) PMID 16244771 </ref><ref name="PMID16244770">Idiopathic intracranial hypertension: associations with thrombophilia and hypofibrinolysis in men. Clin Appl Thromb Hemost 11(4):441-8 (2005) PMID 16244770 </ref><ref name="PMID15821828">The role of plasma exchange in HELLP syndrome. Clin Appl Thromb Hemost 11(2):211-7 (2005) PMID 15821828 </ref><ref name="PMID15821827">The increase of blood anticardiolipin antibody depends on the underlying etiology in cerebral ischemia. Clin Appl Thromb Hemost 11(2):203-10 (2005) PMID 15821827 </ref><ref name="PMID15821825">Clinicohematologic spectrum in patients with lupus anticoagulant. Clin Appl Thromb Hemost 11(2):191-5 (2005) PMID 15821825 </ref><ref name="PMID15678283">Platelet CD61 might have an important role in causing hemorrhagic complication in dengue infection. Clin Appl Thromb Hemost 11(1):112 (2005) PMID 15678283 </ref><ref name="PMID15678280">Argatroban treatment for patients with intolerance to heparin and hirudin. Clin Appl Thromb Hemost 11(1):99-103 (2005) PMID 15678280 </ref><ref name="PMID15678269">Low-molecular-weight heparin for the treatment of venous thromboembolism in the elderly. Clin Appl Thromb Hemost 11(1):15-23 (2005) PMID 15678269 </ref><ref name="PMID15497030">Endothelial injury markers with high-dose intravenous iron therapy in renal failure. Clin Appl Thromb Hemost 10(4):403-6 (2004) PMID 15497030 </ref><ref name="PMID15497029">The importance of platelet counts in dengue infection: 35 cases and literature review. Clin Appl Thromb Hemost 10(4):399-402 (2004) PMID 15497029 </ref><ref name="PMID15497028">Bleeding and other presentations in Thai patients with dengue infection. Clin Appl Thromb Hemost 10(4):397-8 (2004) PMID 15497028 </ref><ref name="PMID15497024">Prevention of venous thrombosis and thrombophlebitis in long-haul flights with pycnogenol. Clin Appl Thromb Hemost 10(4):373-7 (2004) PMID 15497024 </ref><ref name="PMID15497020">Hemostatic abnormalities and changes following bone marrow transplantation. Clin Appl Thromb Hemost 10(4):341-50 (2004) PMID 15497020 </ref><ref name="PMID15497017">Sapheno-femoral junction pathology: molecular mechanism of saphenous vein incompetence. Clin Appl Thromb Hemost 10(4):311-21 (2004) PMID 15497017 </ref><ref name="PMID15247986">Thrombosis and a hypercoagulable state in HIV-infected patients. Clin Appl Thromb Hemost 10(3):277-80 (2004) PMID 15247986 </ref><ref name="PMID15094931">Current debates in antiphospholipid syndrome: the acquired antibody-mediated thrombophilia. Clin Appl Thromb Hemost 10(2):89-126 (2004) PMID 15094931 </ref><ref name="PMID14979404">The altered hemorheologic parameters in thromboangiitis obliterans: a new insight. Clin Appl Thromb Hemost 10(1):45-50 (2004) PMID 14979404 </ref><ref name="PMID14507116">Decreased protein Z concentrations complicating the hypercoagulable state of Behcet's disease. Clin Appl Thromb Hemost 9(3):259-63 (2003) PMID 14507116 </ref><ref name="PMID12812388">Glanzmann's thrombasthenia proposed optimal management during surgery and delivery. Clin Appl Thromb Hemost 9(2):167-70 (2003) PMID 12812388 </ref><ref name="PMID12812378">Flight microangiopathy on long-haul flights: prevention of edema and microcirculation alterations with Venoruton. Clin Appl Thromb Hemost 9(2):109-14 (2003) PMID 12812378 </ref><ref name="PMID12643320">On the prophylactic and therapeutic use of danaparoid sodium (Orgaran) in patients with heparin-induced thrombocytopenia. Clin Appl Thromb Hemost 9(1):25-32 (2003) PMID 12643320 </ref><ref name="PMID12643319">The LONFLIT4-VENORUTON study: a randomized trial prophylaxis of flight-edema in normal subjects. Clin Appl Thromb Hemost 9(1):19-23 (2003) PMID 12643319 </ref><ref name="PMID12121052">Hemostatic abnormalities following bone marrow transplantation. Clin Appl Thromb Hemost 8(2):125-32 (2002) PMID 12121052 </ref><ref name="PMID11991243">The role of the bone marrow examination in the diagnosis of immune thrombocytopenic purpura: case series and literature review. Clin Appl Thromb Hemost 8(1):73-6 (2002) PMID 11991243 </ref><ref name="PMID11991239">Interobserver agreement of complete compression ultrasound for clinically suspected deep vein thrombosis. Clin Appl Thromb Hemost 8(1):45-9 (2002) PMID 11991239 </ref><ref name="PMID11991236">Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care. Clin Appl Thromb Hemost 8(1):1-31 (2002) PMID 11991236 </ref><ref name="PMID11697708">Endothelial dysfunction in the pathogenesis of atherosclerosis. Clin Appl Thromb Hemost 7(4):276-80 (2001) PMID 11697708 </ref><ref name="PMID11697705">Antiphospholipid thrombosis syndromes. Clin Appl Thromb Hemost 7(4):241-58 (2001) PMID 11697705 </ref><ref name="PMID11441980">Plasma markers of endothelial dysfunction in chronic obstructive pulmonary disease. Clin Appl Thromb Hemost 7(3):205-8 (2001) PMID 11441980 </ref><ref name="PMID11292198">Lung scintigraphy and helical computed tomography for the diagnosis of pulmonary embolism: a meta-analysis. Clin Appl Thromb Hemost 7(2):87-92 (2001) PMID 11292198 </ref><ref name="PMID11190910">Erythrocyte aggregation in nonvalvular atrial fibrillation. Clin Appl Thromb Hemost 7(1):75 (2001) PMID 11190910 </ref><ref name="PMID11190905">Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Clin Appl Thromb Hemost 7(1):5-9 (2001) PMID 11190905 </ref><ref name="PMID10898276">Effectiveness of anagrelide in the treatment of symptomatic patients with essential thrombocythemia. Clin Appl Thromb Hemost 6(3):157-61 (2000) PMID 10898276 </ref><ref name="PMID10898273">Effect of sarpogrelate hydrochloride on platelet-derived microparticles and various soluble adhesion molecules in diabetes mellitus. Clin Appl Thromb Hemost 6(3):139-43 (2000) PMID 10898273 </ref><ref name="PMID10726045">The antithrombotic factor singlet oxygen/light (1O2/h nu). Clin Appl Thromb Hemost 6(1):22-30 (2000) PMID 10726045 </ref><ref name="PMID10726042">Thrombolytic drugs in acute myocardial infarction. Clin Appl Thromb Hemost 6(1):1-13 (2000) PMID 10726042 </ref><ref name="PMID10726029">Heparin-induced thrombocytopenia: historical review. Clin Appl Thromb Hemost 5 Suppl 1():S2-6 (1999) PMID 10726029 </ref><ref name="PMID10726036">Antithrombin agents: the new class of anticoagulant and antithrombotic drugs. Clin Appl Thromb Hemost 5 Suppl 1():S45-55 (1999) PMID 10726036 </ref><ref name="PMID10726035">Soluble adhesion molecules in the HIT syndrome: pathophysiologic role and therapeutic modulation. Clin Appl Thromb Hemost 5 Suppl 1():S38-44 (1999) PMID 10726035 </ref><ref name="PMID10726034">Functional heterogeneity of antiheparin-platelet factor 4 antibodies: implications in the pathogenesis of the HIT syndrome. Clin Appl Thromb Hemost 5 Suppl 1():S32-7 (1999) PMID 10726034 </ref><ref name="PMID10726033">Generation and pathogenicity of anti-platelet factor 4 antibodies: diagnostic implications. Clin Appl Thromb Hemost 5 Suppl 1():S28-31 (1999) PMID 10726033 </ref><ref name="PMID10726032">Laboratory diagnosis of heparin-induced thrombocytopenia. Clin Appl Thromb Hemost 5 Suppl 1():S21-7 (1999) PMID 10726032 </ref><ref name="PMID10726031">Inadequacy of current prevention strategies for heparin-induced thrombocytopenia. Clin Appl Thromb Hemost 5 Suppl 1():S16-20 (1999) PMID 10726031 </ref><ref name="PMID10726030">Clinical aspects of heparin-induced thrombocytopenia and thrombosis and other side effects of heparin therapy. Clin Appl Thromb Hemost 5 Suppl 1():S7-15 (1999) PMID 10726030 </ref><ref name="PMID10726000">Acquired von Willebrand disease in monoclonal gammapathies: effectiveness of high-dose intravenous gamma globulin. Clin Appl Thromb Hemost 5(3):152-7 (1999) PMID 10726000 </ref><ref name="PMID10725999">Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia. Clin Appl Thromb Hemost 5(3):147-51 (1999) PMID 10725999 </ref><br />
{| class="wikitable" |<br />
| bgcolor="#dfdfdf" | '''Clincal and Applied Thrombosis and Hemostasis'''<br />
| align="left" width="800" |<br />
|-<br />
| bgcolor="#dfdfdf" | [http://cat.sagepub.com/content/by/year'''ARTIKEL SUCHEN''']<br />
| align="left" width="800" |<br />
|-<br />
| bgcolor="#dfdfdf" | '''Frei verfügbar'''<br />
| align="left" width="800"| öffnet sporadisch<br />
|-<br />
| bgcolor="#dfdfdf" | '''Pubmed'''<br />
| align="left" width="800"| von 1994-1998 nicht erfaßt<br />
|-<br />
| bgcolor="#dfdfdf" | '''Impact Factor'''<br />
| align="left" width="800"| <br />
|-<br />
| bgcolor="#00dfdf" | '''Charakteristik'''<br />
| align="left" width="800"| Hämostaseologie<br />
|-<br />
| bgcolor="#dfdfdf" | '''Übersichtsartikel in Pluspedia'''<br />
| align="left" width="800"| <references /><br />
|-<br />
<br />
[[Kategorie:Medizinische_Zeitschrift]]</div>
Ossip Groth